AmirAli Talasaz, Co-Chief Executive Officer at Guardant Health, Inc. (GH), bought 132,750 shares at $26.04 ($3.4M) on 2023-03-13, disclosed to the SEC on 2023-03-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.78 | 6,094 | $151K | 4.4% |
| 2 | $24.78 | 6,094 | $151K | 4.4% |
| 3 | $24.78 | 12,187 | $302K | 8.8% |
| 4 | $24.78 | 12,187 | $302K | 8.8% |
| 5 | $26.04 | 13,906 | $362K | 10.6% |
| 6 | $26.04 | 13,906 |
| $362K |
| 10.6% |
| 7 | $26.04 | 27,813 | $724K | 21.2% |
| 8 | $26.04 | 27,813 | $724K | 21.2% |
| 9 | $26.40 | 4,250 | $112K | 3.3% |
| 10 | $26.40 | 8,500 | $224K | 6.6% |
| Total | $25.73 avg | 132,750 | $3.4M | 100% |
| Filing → |
| GH | SELL | 2026-05-22 | $23.1M | — | Filing → |
| GH | SELL | 2026-05-13 | $5.0M | — | Filing → |
| GH | SELL | 2025-12-10 | $8.5M | — | Filing → |